Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04105569 · ClinicalTrials.gov registry record · NA

Atlas of Experimental Gingivitis in Humans

A NA study of Gingivitis, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT04105569 is a NA study of Gingivitis that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 6 participants, below the 236-participant average among 25 other Gingivitis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04105569, a NA study of Gingivitis, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

Pilot case series with a split-mouth design to track subjects with known exposure (dental biofilm accumulation) over 21 days. Descriptive design, using single cell RNA sequencing as a "digital biopsy" to catalog and contrast inflamed versus non-inflamed tissues from within the same mouth and across patients. Specimens (human) will biobanked from the 'digital biopsy' site for future analysis, including: Gingival crevicular fluid, oral epithelial stem/progenitor cells, and plaque samples, for 'omics analyses including metabolomics, microbiomic, and genomic data.

Conditions Studied

Interventions

  • PROCEDURE Stent-Induced Biofilm Overgrowth

Study Locations (1)

North Carolina

  • Adams School of Dentistry - Chapel Hill

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2019-10-15
Est. Completion 2019-12-03
Phase NA

What the Registry Record Tells You About NCT04105569

The ClinicalTrials.gov registry entry for NCT04105569 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 236-participant average among 25 other Gingivitis trials with a reported enrollment target (97% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gingivitis appearing as the primary indexed condition, and to 1 intervention - of which Stent-Induced Biofilm Overgrowth is the first listed.

NCT04105569 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04105569 about?

NCT04105569 is a clinical study titled "Atlas of Experimental Gingivitis in Humans". Pilot case series with a split-mouth design to track subjects with known exposure (dental biofilm accumulation) over 21 days. Descriptive design, using single cell RNA sequencing as a "digital biopsy" to catalog and contrast inflamed versus non-inflamed tissues from within the same mouth and across ...

What is the current status of trial NCT04105569?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2019-10-15. Estimated completion is 2019-12-03.

What conditions does trial NCT04105569 study?

This clinical trial studies the following conditions: Gingivitis.

What interventions are being tested in trial NCT04105569?

The interventions under investigation include: Stent-Induced Biofilm Overgrowth (PROCEDURE).

Who is sponsoring clinical trial NCT04105569?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04105569 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gingivitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.